000 01850 a2200541 4500
005 20250516054018.0
264 0 _c20120516
008 201205s 0 0 eng d
022 _a1937-335X
024 7 _a10.1089/ten.TEA.2011.0234
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScotti, Celeste
245 0 0 _aResponse of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1β and low oxygen.
_h[electronic resource]
260 _bTissue engineering. Part A
_cFeb 2012
300 _a362-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCartilage Oligomeric Matrix Protein
650 0 4 _aCartilage, Articular
_xcytology
650 0 4 _aCells, Cultured
650 0 4 _aChondrocytes
_xcytology
650 0 4 _aCollagen Type II
_xmetabolism
650 0 4 _aEpitopes
_xmetabolism
650 0 4 _aExtracellular Matrix Proteins
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGlycoproteins
_xmetabolism
650 0 4 _aGlycosaminoglycans
_xmetabolism
650 0 4 _aHumans
650 0 4 _aInterleukin-1beta
_xpharmacology
650 0 4 _aMale
650 0 4 _aMatrilin Proteins
650 0 4 _aMatrix Metalloproteinases
_xmetabolism
650 0 4 _aMiddle Aged
650 0 4 _aNose
_xcytology
650 0 4 _aOxygen
_xpharmacology
650 0 4 _aTissue Engineering
_xmethods
650 0 4 _aTissue Scaffolds
_xchemistry
700 1 _aOsmokrovic, Andrea
700 1 _aWolf, Francine
700 1 _aMiot, Sylvie
700 1 _aPeretti, Giuseppe M
700 1 _aBarbero, Andrea
700 1 _aMartin, Ivan
773 0 _tTissue engineering. Part A
_gvol. 18
_gno. 3-4
_gp. 362-72
856 4 0 _uhttps://doi.org/10.1089/ten.TEA.2011.0234
_zAvailable from publisher's website
999 _c21142714
_d21142714